Sodium Zirconium Cyclosilicate Improves Dialysis Diet Care
A multicentre trial found the potassium binder plus nutritional counselling eased dietary restriction burdens for haemodialysis patients.
Updated on Nov. 9, 2026 in Nutrition

A multicentre randomised open-label trial found that adding sodium zirconium cyclosilicate (SZC) to nutritional counselling improved quality of life related to dietary potassium restriction and lowered pre-dialysis serum potassium in patients on maintenance haemodialysis. The findings were published in BMC Nephrology and presented at ASN Kidney Week 2026.
Why it matters
Dietary potassium restriction imposes a substantial day-to-day burden on patients undergoing maintenance haemodialysis, making treatments that ease that burden relevant to patient wellbeing. The results offer evidence that medication support may complement counselling for managing potassium levels.
In a randomised open-label trial of 183 patients over 8 weeks, none of the SZC group needed rescue treatment compared with 25 of 92 control patients. The study did not report outcomes beyond the 8-week treatment window.
The players
Yokohama City University Graduate School of Medicine
The Yokohama-based medical school whose researchers led the trial, and which is known for its clinical research in nephrology and other fields.
The details
Outpatients receiving thrice-weekly maintenance haemodialysis with pre-dialysis serum potassium of 5.5 to less than 6.5 mEq/L were assigned to SZC plus standardised counselling or counselling alone. Exploratory analyses showed increased fruit intake without a rise in total dietary potassium, and no serious treatment-related adverse events or deaths were reported.
Timeline
8 weeks: trial treatment period for SZC and counselling arms.
October 22-25, 2026: results presented at ASN Kidney Week 2026.
Health Landscape
The trial's presentation at ASN Kidney Week 2026 places SZC-based potassium management in front of the international nephrology community. The approach focuses on pairing medication with dietary counselling rather than relying on restriction alone.
For haemodialysis patients, the trial suggests that a medication added to dietary counselling may ease potassium restriction and reduce the need for rescue treatment. The researchers emphasised that individualised dietary assessment and regular potassium monitoring remain essential.
The takeaway
Managing dialysis diets is a daily challenge, and this trial points to combining medication with individualised counselling and regular potassium checks. Patients should discuss any dietary changes with their care team before making them.
Further reading
For more on how diet shapes kidney health, explore Nutrition coverage.



